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Very high energy electrons (VHEE) in the range from 100 to 250 MeV have the potential of 
becoming an alternative modality in radiotherapy because of their improved dosimetry 
properties compared with MV photons from contemporary medical linear accelerators. Due 
to the need for accurate dosimetry of small field size VHEE beams we have performed dose 
measurements using EBT2 Gafchromic® film. Calibration of the film has been carried out 
for beams of two different energy ranges: 20 MeV and 165 MeV from conventional radio 
frequency linear accelerators. In addition, EBT2 film has been used for dose measurements 
with 135 MeV electron beams produced by a laser-plasma wakefield accelerator. The dose 
response measurements and percentage depth dose profiles have been compared with 
calculations carried out using the general-purpose FLUKA Monte Carlo (MC) radiation 
transport code. The impact of induced radioactivity on film response for VHEEs has been 
evaluated using the MC simulations. A neutron yield of the order of 10-5 neutrons/cm2 per 
incident electron has been estimated and induced activity due to radionuclide production is 
found to have a negligible effect on total dose deposition and film response. Neutron and 
proton contribution to the equivalent doses are negligible for VHEE. The study demonstrates 
that EBT2 Gafchromic film is a reliable dosimeter that can be used for dosimetry of VHEE. 
The results indicate an energy-independent response of the dosimeter for 20 MeV and 165 





Electron beams have been successfully used over the last fifty years as a modality in radiotherapy. 
Currently, clinical linear accelerators (LINACs) produce electrons with energies up to 22 MeV 
(Hogstrom & Almond, 2006). Such electron beams have limited application in the treatment of 
cancer because their dose distribution in the human body is attenuated steeply in both the 
longitudinal and lateral planes, which makes them unsuitable for treating deep-seated tumours. The 
most common treatment modality utilizes megavoltage X-ray bremsstrahlung-generated radiation 
from clinical LINACs.  The state of the art photon-based intensity modulated radiotherapy (IMRT) 
allows the radiation dose to be conformed very precisely to the three-dimensional (3D) shape of the 
tumour by modulating the intensity of the radiation beam. IMRT has been found to be effective in 
tumour treatment. However, the total integrated dose in normal tissue for IMRT treatment is a factor 
of two higher compared with protons (Lomax et al., 1999). This aspect is particularly critical if the 
target volume is in the vicinity of sensitive organs.  
 In the past decade several studies have revived interest in radiotherapy using very high energy 
electron (VHEE) beams with energies exceeding 150 MeV, which allow maximum dose deposition 
deep in tissue. Previous theoretical studies using the PENELOPE code (DesRosiers et al., 2000, 
Moskvin et al., 2010) have shown the potential of 150–250 MeV VHEE beams for radiotherapy. 
The effective range of such beams can exceed 40 cm and, moreover, lateral scattering of high-
energy electrons in tissue is sufficiently small for use in IMRT treatment of deep seated tumours 
(Fuchs et al., 2009, Yeboah & Sandison, 2002). Furthermore, the potential clinical advantage of 
electron beams with energies exceeding 100 MeV have been studied for lung cancer (DesRosiers et 
al., 2008a) and prostate cancer treatment (DesRosiers et al., 2008b). These studies conclude that 
electron beams with energies above 100 MeV can achieve a very good dose conformation, 
comparable with or even exceeding those of current photon modalities, while offering significantly 
better dose sparing of healthy tissue (Yeboah et al., 2002). Advantages of VHEE beams include the 
possibility of irradiating the target volume from several different directions simultaneously, their 
small penumbra and high dose rates.  
 Conventional VHEE LINACs based on radio frequency (RF) cavities are large devices due 
to the limited accelerating gradient (<10 MV/m), imposed by electrical breakdown. Their large size 
(many meters in length) and high cost have limited the development of LINAC-based VHEE 
applications. The laser-plasma wakefield accelerator (LWFA), on the other hand, is a very compact 
accelerator with accelerating gradients exceeding 100 GV/m, which enables energies in the 100-250 
MeV range to be obtained from mm-scale accelerators (Faure et al., 2004, Geddes et al., 2004, 
Mangles et al., 2004). Electron beams from LWFAs can also have unique properties: ultra-short 
pulse duration (1-3 fs)(Lundh et al., 2011), low energy spread (GE/E<1%) (Wiggins et al., 2010), 
low transverse emittance (Hn < 1 S mm mrad) and high peak current (> 1 kA) (Brunetti et al., 2010). 
Their compactness and their high quality electron beams makes them an attractive candidate for 
VHEE radiotherapy (Fuchs et al., 2009).  
The feasibility of laser-plasma accelerated electrons as a treatment modality in radiotherapy 
has been theoretically investigated (Glinec et al., 2006) and, despite a number of simulation studies 
of LWFA electrons, very few experiments have been carried out. Richter (Richter et al., 2011) 
presented dosimetry studies of low energy LWFA electrons (energy ranges corresponding to clinical 
LINACs). Lundh (Lundh et al., 2012) conducted a study of 120 MeV LWFA electron beams. 
However, no absolute dosimetric measurements have been published. Absolute dosimetry 
measurements for high energy electron beams are extremely important for radiobiology 
experiments because knowledge of the dose delivered is an essential part of evaluating 
radiobiological outcome. Absolute dosimetry presents a challenge for small field size beams due to 
high level of non-equilibrium dose deposition caused by scattering of primary particles from the 
small beam (Das et al., 2008).  
Gafchromic film is a common dosimetry tool for external beam radiotherapy and 
brachytherapy (Devic, 2011). It has a high spatial resolution, tissue equivalence and has been 
successfully applied for a wide range of radiotherapy modalities.  
In this paper we present dosimetric measurements using EBT2 Gafchromic film for a wide 
range of electron beam energies. Measurements have been made using three different accelerators: a 
20 MeV clinical LINAC, a 165 MeV conventional linear accelerator and a 135 MeV laser-plasma 
wakefield accelerator. The measurements have been compared with Monte Carlo simulations using 
the FLUKA general purpose code, which has been widely validated and benchmarked with 
experimental data (Ferrari et al., 2005, Battistoni et al., 2007, Parodi et al., 2007, Robert et al., 
2013, Randeniya et al., 2009). 
The potential risks of VHEE radiotherapy due to secondary neutron  photo-production  has 
been raised by Bortfeld in 2004 (Papiez et al., 2004). Above an energy threshold, which varies from 
10 to 19 MeV for light nuclei and from 4 to 6 MeV for heavy nuclei (IAEA, 1979), neutron 
production occurs in all materials arising from the electron or bremsstrahlung beam. Therefore, the 
application of very high energy beams requires careful consideration of the neutron generation and 
induced radioactivity from the standpoint of additional dose delivered and radiation protection. 
These aspects have been extensively described in the literature (Swanson 1978, NCRP, 2003, 
Barbier, 1969). The main channel of neutron production for VHEEs are (Ȗ,n), (Ȗ,p), (Ȗ,2n) and 
(Ȗ,pn) reactions. To address the concern raised by Bortfeld, the neutron yield generated by VHEEs 
has been calculated. To assess radiation safety, we have used MC simulations to investigate 
activation and the equivalent doses after irradiation with VHEEs. This also enables any additional 
dose deposited in the EBT2 film due to induced activity to be evaluated. 
 
2. Materials and methods 
 
2.1. Irradiation setup 
 
2.1.1 ALPHA-X laboratory 
 
The ALPHA-X laser–wakefield accelerator beam line (Figure 1) in the Terahertz to Optical Pulse 
Source (TOPS) facility (Jaroszynski et al., 2000) at the University of Strathclyde has been used to 
conduct experiments using LWFA VHEE beams. High power Ti:sapphire laser pulses (wavelength Ȝ 
= 800 nm, duration = 35 fs, energy = 0.9 J, peak intensity I = 2 × 1018 Wcmí2) are focused with an 
F/18 spherical mirror to a spot size of 40 ȝm (1/e2 diameter) on a 2 mm diameter pulsed supersonic 
helium gas jet, producing a 10 ȝm diameter relativistic plasma channel with a density of ~1.3 × 1019 
cmí3. High energy electron beams from the laser-plasma wakefield accelerator are imaged using a 
series of insertable Lanex (KODAK) phosphor screens positioned along the beam line axis.  
 
 
Figure 1. A schematic of the ALPHA-X laser-plasma wakefield accelerator, showing the positioning of the gas jet 
accelerator relative to the key detection systems and dosimetry measurements setup. 
 
A 22 cm long water phantom (15 × 30 × 22 cm3) is placed 185 cm after a 50 ȝm thick Mylar 
vacuum window. A set of 10 EBT2 Gafchromic film sheets are equi-spaced every 2 cm along the 
beam axis in the water tank. Characterization of the electron energy spectra is carried out using a 
magnetic dipole imaging electron spectrometer over the range 80–240 MeV. Electron spectra are 
observed on scintillating Ce:YAG crystals positioned in the focal plane of the spectrometer and the 
image is captured on a 12-bit CCD camera. Charge recorded using Fuji BAS-SR image plates 
(Paterson et al., 2008) is on average between 5 and 10 pC/shot. Typical r.m.s. bunch lengths of the 
laser-plasma accelerated electron bunches are in the range of 1-10 fs (Shanks, 2012). To estimate 
the charge density during the experiment, a bunch length of 5 fs has been assumed because of 
dispersion arising from the beam energy spread, which gives a peak current of the order of 1 kA at 
the entrance to the phantom, delivering ~12 mGy/pulse at 1.8 cm depth. The accelerator pulse 
repetition rate is restricted to 0.33 Hz for the dosimetry measurements. Following optimal 
collimation and focusing of the beam using permanent and electromagnetic quadrupole magnets, 
the mean transverse cross-sectional diameter of the Gaussian beam at the entrance of the water tank 
is 1.6 cm full-width at half-maximum (FWHM). 
  
 
2.1.2. Royal Surrey Hospital LINAC 
 
Irradiation with 20 MeV electron beams on a Varian Clinac iX (Varian) linear accelerator (Varian 
Medical Systems, Inc., Palo Alto, CA) has been carried out at the Royal Surrey County Hospital. 
This LINAC operates at 180 Hz pulse repetition rate, delivering 400 cGy/minute at dmax (that 
corresponds to 3.7 mGy/pulse) and produces microsecond duration nanocoulomb electron bunches 
at milliampere average current in a macro-pulse. 
 
2.1.2.1 Phantom and irradiation procedure for the Surrey Hospital LINAC 
 
For exposure to the 20 MeV electron beam, the films are placed in a standard grade solid water 
phantom (Gammex, Middleton, WI) composed of 20 × 20 cm2 slabs with 5 cm of build-up material 
above the film and 15 cm under the film, to provide adequate backscatter. The individual films are 
positioned at a depth corresponding to 95% of the maximum dose for the 20 MeV electron beam. 
The source-to-surface distance (SSD) is set to 100 cm, as commonly used in radiation therapy with 
the MeV electron beams. Exposure of the films used for dose calibration is carried out using a 
10 × 10 cm2 field size, and the film is positioned perpendicularly to the axis of the beam. 
Calibration films are produced for five discrete exposures for doses ranging from 10 cGy to 100 
cGy. One film is used for each dose level. Prior to irradiation, the output beam is characterized 
using an N34001 Roos® plane-parallel ion chamber (PTW, Freiburg, Germany) calibrated by the 
National Physical Laboratory (Teddington, UK). 
 
2.1.3 INFN SPARC LAB 
 
The SPARC (Sources for Plasma Accelerators and Radiation Compton with Lasers and Beams) 
LINAC test bench beamline (SPARC) has been used to perform reference dosimetry measurements 
for VHEE beams. 
The SPARC photoinjector consists of a 1.6-cell S-band RF gun of the BNL/UCLA/SLAC 
type (Palmer, 1998) with a Cu photocathode (peak electric fields of 120-140 MV/m) and produces a 
5.6 MeV electron injection beam. Three S-band travelling wave accelerating sections raise the 
energy to approximately 170 MeV (Alesini et al., 2003). The transport system consists of 8 
electromagnetic quadrupoles, which allow tuning of the beam properties at the target. All dosimetry 
measurements are performed in a 30 × 30 × 30 cm3 water phantom placed 41 cm after a 3 mm thick 
Perspex window. The energy of the SPARC electron beam for the experiment is set to 165 MeV, 
and the r.m.s. bunch length duration is 0.87 ps with an average charge of 60 pC/shot, giving an 
electron peak current of ~100 A and delivering ~190 mGy/pulse at the depth of 1.3 cm. The FWHM 
transverse beam diameter is 0.8 cm at the entrance to the water tank. 
 
2.1.3.1. Irradiation procedure of calibration films in SPARC LINAC 
 
For exposure to a 165 MeV electron beam from the SPARC LINAC, the films are placed in a water 
phantom at a depth of 2.8 cm from the front wall. EBT2 films are exposed to 6 discrete dose levels 
that correspond to different number of delivered pulses.  
 
2.2. Radiochromic EBT2 films 
 
EBT2 Gafchromic® film (Ashland, 2013b) is a common secondary dosimeter used in clinical 
radiation therapy. The properties and sensitivity of EBT2 film have been well documented for a 
wide range of energies for different radiation sources used in radiotherapy (Andres et al., 2010, 
Arjomandy et al., 2010, Arjomandy et al., 2012, Butson et al., 2010, Ashland, 2013b, Lindsay et 
al., 2010, Reinhardt et al., 2012). The MC calculated absorbed-dose energy dependence has been 
found to be constant for monoenergetic photon beams in the energy range from 100 kV to 18 MV 
(Sutherland & Rogers, 2010). Data provided by the manufacturer indicates that the film sensitivity 
may be as much as 10% higher for kV X-rays compared with MV X-rays (Ashland, 2013a). The 
energy dependence of EBT2 film (apart from kV X-ray beams) has been found to be relatively 
small within measurement uncertainties ı = 4.5%) for all radiotherapy energies and modalities 
(photon, electron and proton beams) (Arjomandy et al., 2010).  These energies for electron beams 
are substantially lower than those studied here. 
 
2.2.1. Film irradiation, digitising and handling procedure 
 
The films used in the study are Gafchromic® EBT2, with sheet dimensions of 20.3 × 25.4 cm2. 
They are handled according to the procedures described in the AAPM task group 55 report 
(Niroomand-Rad et al., 1998). After irradiation, exposed as well as unexposed (for background 
correction) film pieces are stored together in black envelopes at room temperature to minimize 
exposure to light. 
The films are scanned and digitized with an Epson Expression 10000XL Pro flat-bed colour 
scanner. The scanner is fitted with a transparency adapter and the images are acquired in 
transmission mode. RGB positive images are collected with 16 bit depth resolution per colour 
channel and a spatial resolution of 72 dpi. Software settings are chosen to disable all colour 
correction options and thereby produce raw scanner data without photographic enhancements. To 
account for the post-exposure changes all calibration films are scanned 24 ± 2 hours after exposure. 
Under these conditions errors due to time-after-exposure differences can be neglected (Ali et al., 
2002). It is well known that the response of EBT2 radiochromic film is sensitive to its orientation 
on the scanner (Paelinck et al., 2007). Therefore, the film orientation in each image is recorded. The 
scanner response of EBT2 film is also sensitive to the position of the film on the scanner relative to 
the scan axis (Chung et al., 2010), therefore a plastic template is used to position films in a 
reproducible central location in the middle of the scan window, where no correction of scan field 
uniformity is required. Ten preview scans are taken before the start of film scanning to allow the 
scanner temperature to stabilize and, thus, prevent any temperature-dependent response effects. 
Each film is scanned three times post-irradiation and the average of three scans is used for analysis. 
For film analysis, raw pixel values from the red colour channel (PVR) are converted into net optical 
density value (netOD) employing following formula:  
 ݊݁ݐܱܦ = ܱܦ௘௫௣ െ ܱܦ௨௡௘௫௣ = െlog ൬ ௉௏ೃ೐ೣ೛௉௏ೃೠ೙೐ೣ೛൰, (1) 
 
where ODexp, ODunexp, PVexp and PVunexp are the measured optical densities and pixel values of 
exposed and unexposed film, respectively. 
 
2.2.1.1. Image processing 
 
The images of the scanned films are imported into an in-house routine written in ImageJ (National 
Institutes of Health, Bethesda, MD) that extracts the red component of the RGB scanned image and 
determines the netOD of the irradiated film patches. 
 
2.3 Monte Carlo simulation 
 
 
The multi-purpose Monte Carlo radiation transport code FLUKA 2011.2b.4 has been used to 
simulate dose deposition of VHEE beams in the active layer of the EBT2 film for both ALPHA-X 
and SPARC beamlines. The dosimeter is modelled as a 5 × 5 cm2 sheet composed of five layers: a 
polyester over-laminate, an adhesive layer, a topcoat, the active layer and a polyester substrate. 
Schematic diagrams of these structures are shown in Figure 2 and the composition, thickness and 
density of the layers can be found in Table 1. The film is embedded in a 30 × 30 × 30 cm3 water 
phantom surrounded by 6 mm thick poly-methyl methacrylate (PMMA) walls.  
 
Table 1. Configuration and atomic composition of Gafchromic® EBT2 film used for MC calculations.  
Layer 7KLFNQHVV>ȝP@ Density [g/cm2] COMPOSITION (ATOM%) 
H Li C N O Cl K Br 
Polyester film base 50 1.35 36.4 0.0 45.5 0.0 18.2 0.0 0.0 0.0 
Adhesive 25 1.2 57.1 0.0 33.3 0.0 9.5 0.0 0.0 0.0 
Topcoat 5 1.2 56.9 0.9 25.7 0.0 15.6 0.9 0.0 0.0 
Active layer 30 1.2 58.3 0.8 29.6 0.1 10.7 0.3 0.1 0.1 
Polyester film base 175 1.35 36.4 0.0 45.5 0.1 18.2 0.0 0.0 0.0 
           
Overall composition   40.85 0.10 42.37 0.01 16.59 0.04 0.01 0.01 
 
 
Each accelerator beam has been modelled separately. The source for the SPARC beamline is 
a Gaussian beam with 0.43 × 0.35 cm2 FWHM size, with 15 mrad full angle divergence. The 
average energy for a bunch in the SPARC beamline is set to 165 MeV, with a 0.5% energy spread 
approximated by a Gaussian distribution. To calculate the dose deposited in the calibration films the 
active layer of EBT2 film positioned at depth of 2.8 cm from the front wall of the water tank has 
been scored.   
As the ALPHA-X LWFA VHEE beam exhibits shot-to-shot variations in lateral beam 
profile, the field shape and size is averaged over the number of shots. This profile is well 
approximated by a Gaussian with 0.75 cm by 0.7 cm FWHM field size and 8 mrad divergence. User 
written FLUKA SOURCE subroutine (Ferrari et al., 2005) is used to sample energy from 
experimental cumulative energy distribution curve over hundreds of shots.  
 
 
Figure 2. Configuration of Gafchromic® EBT2 Dosimetry Film  (Ashland, 2013a). 
The dose is scored in the active layer of the EBT2 film. The induced radioactivity is computed 
using RESNUCLEi cards (Ferrari et al., 2005) with different time points to determine activity for 
various post irradiation times. Ambient dose equivalent H*(10) from residual activity produced in 
the film by an electron beam is calculated using ICRP 74 data AMB74 (Pelliccioni, 2000). AMB74 
model adopts ICRP 74 (ICRP, 1996),  (Pelliccioni, 2000) data and contains conversion coefficients 
for protons, neutrons, charged pions, muons, photons and electrons. 
The set of parameters PRECISIO (Ferrari et al., 2005) are used to configure the physical model for 
the simulations. In these simulations electron/positron and photon production thresholds are set to 
10 keV. The LAM-BIAS (Ferrari et al., 2005) utility is applied for the photonuclear reaction 
simulation with the Ȝ (Ferrari et al., 2005), inelastic setting coefficient, of 0.001. In the simulation 
for VHEE LINAC, 94 pulses with a duration of 0.8 ps contain 3.3×108 e/pulse. 1×107 initial 
electrons trajectories are used for the calculation. 
Neutron fluence inside and around the target (water phantom) is scored using the USRBIN (Ferrari 
et al., 2005) scoring card. Because of the smaller photo nuclear cross-sections for electromagnetic 
interactions with atoms and electrons, the interaction length for nuclear inelastic interactions of 
photons is reduced in the water, the walls of the PMMA tank and all layers of EBT2 films by a 





3.1. EBT2 film calibration with 20 MeV electron beam 
 
The measured dose response for EBT2 film (lot#: A08301204) irradiated with the 20 MeV Varian 
iX C LINAC is shown in Figure 3, where dose (in Gy) is plotted against netOD. The response curve 
is fitted with a third order polynomial. Fit parameters are given in Table 2. Uncertainties in the dose 
results in uncertainties of the netOD measurement in addition to the parameters determined during 
film calibration (Devic et al., 2004). Dose uncertainties (Bouchard et al., 2009) for lot# A08301204 
related to fit parameters are 3.75% at 10 Gy dose level for the calibration fit used. Accounting for 
additional uncertainty in the measured netOD, the combined standard uncertainty relative to the 
fitted dose in percentage has been determined according to the Joint Committee for Guides in 
Metrology (JCGM, 2008) at various dose levels; for 10 cGy and 100 cGy it is 3.6% and 4.2%, 
respectively. To avoid errors due to self-development of OD, the wait-time interval for reading OD 
(postexposure) of all the films in the experiments is the same as the wait-time interval used to 
generate the calibration curve, i.e. 24±2 hours. 
Two different batches of EBT2 films have been used during the experiment: lot#  
A08301204 for 20 MeV LINAC and INFN LINAC, and lot# A04181101 for the ALPHA-X laser-
plasma accelerated electron beam. For the investigated dose levels, the batch-to-batch film response 
varies due to small variations in film composition. We have quantified the systematic uncertainty 
for the two EBT2 film batches within dose-levels for these studies using a calibrated 225 kV X-ray 
source. For the investigated EBT2 film lot numbers the maximum difference relative to fitted dose 
is 6% and 10.1 % for 10cGy and 100 cGy dose levels, respectively. 
The calibration curve from the experiment with 20 MeV electrons is used below for the 
comparison of measurements with VHEE and the results of the Monte Carlo simulations. 
 
 Figure 3. EBT2 film calibration curve (lot#: A08301204) used in this study. 
 
Table 2. Fit parameters of dose response curve. The fitting equation is: ܦ(݊݁ݐܱܦ) = ܣ଴ + ܣଵ ή ݊݁ݐܱܦ + ܣଶ ή
(݊݁ݐܱܦ)ଶ + ܣଷ ή (݊݁ݐܱܦ)ଷ  . 
Fit parameters ǻDtot [%] 
A0 [Gy] A1 [Gy] A2 [Gy] A3 [Gy] 4.2 0.0014±0.0079 9.05±0.16 9.57±0.88 26.60±1.23 
 
 
3.2. EBT2 film calibration with 165 MeV electron beam 
 
The EBT2 films (lot#: A08301204) irradiated with 165 MeV SPARC electron beam have been 
analysed using the calibration curve shown in Figure 3. The measured and calculated values for 165 
MeV irradiation dose maps are shown in Figure 4, and the irradiation parameters with dose 
uncertainties are given in Table 3.   
 
 
Figure 4. Measured and calculated dose maps of EBT2 films (lot#: A08301204) irradiated with 165 MeV electron 
beam.   
Table 3. The summary of measured and calculated absorbed doses in EBT2 film on the beam central axis. 










run I 11 56.5 3.2 2.7 ± 0.1 2.9 ± 0.1 
run II 20 69.1 4.5 5.7 ± 0.3 5.8 ± 0.2 
run III 38 64.3 4.4 10.0 ± 0.6 10.0 ± 0.4 
run IV 41 57.7 2.4 9.7 ± 0.3 9.8 ± 0.4 
run V 62 55.1 4.9 13.2 ± 1.0 13.0 ± 0.7 
run VI 59 56.8 4.0 14.0 ± 0.6 14.1 ± 0.7 
 
 
3.3.Depth-dose measurements for VHEE 
 
The measured EBT2 film depth-dose profiles (obtained from the calibration curve shown in Figure 
3) along the central beam axis for the SPARC LINAC and ALPHA-X (LWFA) accelerators are 
given in Figure 5 and Figure 6. The combined standard uncertainties of measured dose for both 
EBT2 lot numbers have been calculated for every dose level. The FLUKA simulated energy 
deposition curves representing absolute dose delivered are also shown in Gy. All dose 
measurements in these studies are calibrated using the calibration curve shown in Figure 3.  
 
The lateral profiles have a strong dependence on initial beam divergence. The laser-plasma 
accelerated ALPHA-X electron beam has a quasi-Gaussian lateral profile at the entrance of the 
water phantom. This shape is due to multiple Coulomb scattering of the beam while propagating in 
air. Coulomb scattering in water leads to an increased lateral dose distribution area along the 
propagation direction and thus to a decreased peak dose measured by the Gafchromic® film sheets 
located in the water tank. 
 
 
Figure 5. (a) Depth dose profile for 165 MeV electron beam from the SPARC beamline. (b) Evolution of the FWHM 
beam profile as a function of depth within the water phantom. 
(a) (b) 
 Figure 6. Depth dose profile for 135±44 MeV (r.m.s) laser-plasma accelerated electron beam in the ALPHA-X 
laboratory (b) Evolution of the FWHM beam profile as a function of depth within water phantom. 
 
3.4.Monte Carlo simulations 
 
3.4.1. Depth dose characteristic 
 
A set of Monte Carlo simulations in water have been performed to evaluate the dose distribution for 
VHEE beams generated by the LWFA. Both the ALPHA-X beamline and conventional high energy 
LINAC (SPARC) are simulated in this way. Results of these simulations are presented in Figures 5, 
and 6. Ten million particles have been used for the calculations. The evaluated statistical uncertainty 
on the beam axis is below 1 % up to 6 cm depth and reaches 2.5% at the depth of 20 cm for the 
ALPHA-X beam, while for the SPARC beam it is below 1% for the depth range of 0-20 cm and 
increases to 2% at 30 cm depth. The MC calculated dose uncertainties shown in Figures 5(a) and 
6(a) are dominated by the charge variation during irradiation. 
 
3.4.2. Evaluation of neutron production 
 
 
Figure 7. Neutron fluence inside and around the 30×30×30 cm3 water phantom with transversely distributed EBT2 
films for 165 MeV beams. 
(a) (b) 
The neutron fluence (neutrons/cm2), shown in Figure 7, is of the order of 10-5 neutrons per 
incident electron (~104 neutrons/(cm2ÂGy) in the area of dose deposition and 10-7 (~102 




The activity has been scored for the first (0.3 cm depth), middle (14.3 cm depth) and last film (29.3 
cm depth) distribution within the water tank for each layer of EBT2 film separately. The results 
expressed in absolute values (Bq) and percentage activity are presented in Table 4, for 
Gafchromic® EBT2 films irradiated with the SPARC LINAC. The activation due to the generation 
of radionuclides has been evaluated for each film layer separately. 
 
Table 4. Activation in first, middle and last EBT2 film irradiated in the SPARC beamline calculated for various post 
irradiation times specified for each film layer. 
(*) PO- polyester layer, ADL- adhesive layer, TC- topcoat, ACL – active layer, PS- polyester substrate 
 
 
Activity in films at all depths for adhesive layer, topcoat and active layer 1 minute after the 
beam irradiation ceased is determined by ܥ଺ଵଵ  (22.3 minute half-life) and ଼ܱଵହ  (122.4 s half-life) 
radionuclides with the activity specified in Table 4. 20 min post-irradiation, the activity has been 
determined in these 3 layers of the film mostly by ܥ଺ଵଵ . In the protective polyester layers, activation 
of the ܥ଺ଵଵ  radionuclide is significant. 
In absolute terms, the total activity for the whole film irradiated in SPARC is 1.6 Bq, 16.5 
Bq and 19.5 Bq, for the first (0.3 cm depth) middle (14.3 cm depth) and last (29.3 cm depth) film, 
respectively, 20 min post irradiation. In comparison, the total activity for the ALPHA-X beam in 
corresponding positions of the films in the water tank (at 1.8, 9.8 and 19.8 cm) is 6.1 Bq, 22.7 Bq  
and 33.9 Bq, respectively. The amount of the radionuclides scored in EBT2 films increases towards 
exit of the water tank where the majority of (Ȗ,n) reactions occur. The difference in total activity 
corresponds to the difference in the dose delivered and the field size of the beams in the SPARC and 




 after 1 min [Bq(%)] 
radionuclide  activity  
after 5 min [Bq(%)] 
radionuclide activity  
after 10 min [Bq(%)] 
radionuclide activity 
 after 20 min [Bq(%)] 
depth 
[cm] layer(*) ܥ଺ଵଵ  ଼ܱଵହ  ܥ଺ଵଵ  ଼ܱଵହ  ܥ଺ଵଵ  ଼ܱଵହ  ܥ଺ଵଵ  ଼ܱଵହ  
0.3 
PO 0.96(93.18) -- 0.84(100) -- 0.7(100) -- 0.5(100) -- 
ADL 0.43(40.38) 0.58(53.83) 0.38(70.15) 0.15(27.47) 0.32(90.65) 0.03(7.68) 0.23(98.39) -- 
TC -- -- -- -- -- -- -- -- 
ACL 0.38(30.59) 0.81(65.04) 0.32(57.55) 0.21(35.94) 0.28(81.92) 0.04(11.07) 0.20(94.47) -- 
PS 0.98(95.58) -- 0.84(100) -- 0.72(100) -- 0.51(100) -- 
14.3 
PO 9.62(98.21) -- 8.4(100) -- 7.09(100) -- 5.04(100) -- 
ADL 4.26(37.38) 7(61.33) 3.72(67.08) 1.79(32.34) 3.14(89.97) 0.33(9.38) 2.24(99.02) -- 
TC 3.25(25.29) 8.89(69.14) 2.48(53.91) 2.28(43.29) 2.40(82.02) 0.42(14.24) 1.7(95.76) -- 
ACL 4.26(34.12) 7.6(60.90) 3.72(63.52) 1.59(33.30) 3.14(87.12) 0.36(9.88) 2.23(97.30) -- 
PS 9.58(98.19) -- 8.36(99.98) -- 7.05(100) -- 5.02(100) -- 
29.3 
PO 11.60(97.78) -- 10.10(100) -- 8.55(100) -- 6.09(100) -- 
ADL 5.02(39.80) 7.30(57.94) 4.38(69.42) 1.87(29.69) 3.69(90.64) 0.34(8.38) 2.63(98.83) -- 
TC 4.19(27.39) 10.2(66.54) 3.66(57.08) 2.61(40.75) 3.09(84.52) 0.48(13.05) 2.20(96.96) -- 
ACL 4.82(33.20) 9.10(62.68) 4.21(61.49) 2.33(34.35) 3.55(85.64) 0.43(10.27) 2.53(96.19) -- 
PS 11.3(97.65) -- 9.83(100) -- 8.29(100) -- 5.90(100) -- 
 3.4.4. Equivalent dose 
 
To confirm that activated doses do not present any safety concerns, the equivalent doses due 
to induced radioactivity have been calculated for the experimental conditions for the SPARC and 
ALPHA-X beamlines, separately. Table 5 and Table 6 present the values of H*(10) dose equivalent 
at 1 mm from the front and rear wall of the water tank surface for various post irradiation times 
during the dosimetry study in the SPARC and ALPHA-X beam lines, respectively. The post-
irradiation time is set to a maximum of 20 minutes, such that equivalent dose rates are significantly 
less than natural background levels (~ 100 pSv/s), after which the films are removed from the water. 
  
Table 5. Dose equivalent H*(10) values calculated at 1 mm distance from the front and the rear wall of the water tank 
for various post-irradiation times for the SPARC beam. 
 
front surface rear surface 








1 min 125.31 0.53 571.56 0.56 
5 min 36.70 0.48 175.74 0.45 
10 min 11.46 0.45 61.04 0.24 
15 min 6.07 0.57 35.37 0.20 
20 min 4.42 0.64 26.71 0.23 
 
 
Table 6. Dose equivalent H*(10) values calculated at 1 mm distance from the front and the rear wall of the water tank 
for various post-irradiation times for the ALPHA-X beam. 
 
front surface rear surface 








1 min 69.41 0.34 345.14 0.18 
5 min 25.04 0.23 144.61 0.22 
10 min 11.34 0.12 78.79 0.30 
15 min 1.47 0.20 56.49 0.11 
20 min 0.73 2.40 47.39 0.36 
 
20 minutes after irradiation the H*(10) values are at the level of 26 and 47 pSv/s for the 
SPARC and ALPHA-X beams, respectively. 
 
3.4.5. LET spectrum 
 
The LET spectrum for the ALPHA-X beam (Figure 8) has been scored using the FLUKA 
USRYIELD utility.  
 
 Figure 8. LET spectra calculated for 135 MeV ALPHA-X electron beams at EBT2 films positioned at 1.8, 9.8 and 19.8 
cm in the water bath. The calculated 20 MeV electron LET spectrum is included for comparison. 
 
The LET spectra for the ALPHA-X beam have a maximum at 0.39 keV/ȝm, and a long tail 
decaying with increasing LET values. There is a visible LET peak downshift to 0.35 keV/ȝm for the 
20 MeV electron beam.  
 
4. Discussion  
 
Previous Monte Carlo studies (DesRosiers et al., 2000, Moskvin et al., 2010, Yeboah et al., 2002) 
came to the conclusion that VHEE beams have favourable penetrating properties and can achieve a 
very good dose conformation, comparable with or even exceeding the properties of current photon 
modalities. However, until now no absolute dosimetric evaluation for VHEEs has been available. 
Our studies present a reliable method of performing dose measurements for very high energy 
electron beams. 
The measured dose maps of EBT2 calibration films using the 165 MeV electron beam, shown in 
Figure 4, agree well with Monte Carlo calculations. The main uncertainties in simulations arise 
from charge/shot jitter, which has been quantified in Table 3 for the dose deposited by the SPARC 
VHEEs at the beam central axis.   
The measured depth dose profiles along the central axis of the beam (established in absolute 
terms) with transversely orientated EBT2 films in the water phantom for the 165 MeV LINAC 
(Figure 5 (a)) and 135 MeV laser-plasma generated (Figure 6 (a)) beams are in excellent agreement 
with the Monte Carlo calculations. The difference in depth dose profiles between VHEE LINAC 
and LWFA electrons result from their distinct beam parameters i.e. primary energy, divergence and 
lateral beam size. For 165 MeV electrons from the SPARC beamline, the beam emerging from the 
water tank has a field size of 0.8 cm FWHM with a 15 mrad divergence. In the case of ALPHA-X 
electrons the beam field size is twice as large: 1.6 cm FWHM and a divergence of 8 mrad. 
Therefore the practical range (Rp) for the ALPHA-X beam exceeds that of the SPARC beam. It is 
well known that with a reduction of field size there is a lower level of lateral electronic equilibrium 
at the beam central axis. As a consequence, the depth dose should show high sensitivity to field 
shape and size (Podgorsak, 2005). The clinical beams used in dosimetry of radiotherapy LINACs 
have a field size of at least 10 cm × 10 cm to achieve scatter equilibrium. A clinical LINAC 
electron beam is uniform and broad because of the scattering foils that are commonly used. When 
the field size is reduced significantly, as in the case of the VHEE beams studied, electrons from the 
periphery of the field are not scattered sufficiently to contribute to the central axis depth dose, and 
therefore Dmax moves closer to the entrance (front wall) of the water phantom, which is obvious in 
Figure 5(a) and Figure 6(a). This effect has also been observed by (Lundh et al., 2012) for a LWFA 
electron beam with a diameter of approximately 0.2 cm. However, this work did not include any 
absolute dose measurements because the detector used in the studies, image plates (IP), are not 
designed to measure absorbed dose. In clinical applications, VHEE beams can be scanned using 
electromagnetic magnets to deliver intensity-modulated radiation treatment (Papiez et al., 2004). 
Since this method of the beam delivery will not involve the interaction of the electron beam with 
any type of the flattening filter, the neutron contamination from the machine head is minimized. 
The evolution of FWHM beam lateral profiles at various depths in the water phantom for 
SPARC (Figure 5(b)) and ALPHA-X (Figure 6(b)) strongly depend on the initial beam divergence 
and even though the initial beams for the two are within a factor of 2 in size, the FWHM field size 
close to the rear of the water phantom for the two cases is approximately the same due to multiple 
Coulomb scattering which deflects electrons transversely. The beam profile at the rear of the water 
phantom has a much larger diameter than that of the initial profile. 
For VHEEs, there are two regions of photon energies with respect to neutron production 
mechanisms, i.e. the giant dipole resonance (GDR) giving rise to a (Ȗ,n) reaction threshold that is 
approximately equal to the binding energy of the nucleon (for photon energies between the 
threshold and 40 MeV), and processes above the giant resonance are more important for high Z 
number materials. The neutron yield also increases with the bremsstrahlung contribution. This is 
pronounced in Figure 7, which shows the quasi-isotropic neutron fluence around and inside the 
water phantom. As the VHEE beam propagates through water the mean and peak electron energy 
decreases while the bremsstrahlung photon flux increases with increasing depth. The isotropic 
nature of the neutron emission is due to the dominance of the GDR mechanism (Mao et al., 1996), 
where the emitted neutrons are due to evaporation neutrons from a compound nucleus. The 
deviation from ideally isotropic behaviour for VHEEs is a consequence of anisotropic emission of 
neutrons from other processes such as quasi-deuteron effects where photons interact with the 
neutron-proton pair within the nucleus, rather than the nucleus as a whole. These studies involve the 
estimation of neutron flux generated in water that contributes to the dose delivered inside the 
phantom. The Monte Carlo calculated neutron fluence inside the phantom for 165 MeV VHEEs is 
of the order 10-5 neutrons/(cm2Âprimary electrons). This value is almost three orders of magnitude 
lower than the results for 150 MeV electrons presented in previous studies based on a semi-
empirical evaluation (DesRosiers et al., 2000) established for a higher particle beam density 
approach. According to Howell et al. (Howell et al., 2009) the neutron fluence due to secondary 
neutron emission in the Varian 21 EX, for 20 MV nominal X-ray energy at the depth of the 
maximum dose for 10×10 cm2 field, is 1.69Â105 neutrons/(cm2ÂMU)  This value is one order of 
magnitude larger than the neutron fluence calculated inside a water phantom irradiated with 
VHEEs. The total activity of the films due to radioisotope generation in both SPARC and ALPHA-
X beamlines is of the order of 10 Bq, depending on the film position inside the water tank (details 
on induced activity for the SPARC beam in Table 4). The induced activity increases slightly with 
increasing depth due to the accumulation of bremsstrahlung generation downstream where the 
majority of (Ȗ,n) reactions occur. The dose equivalent rates due to low induced radioactivity of ܥ଺ଵଵ  
and ଼ܱଵହ  play a minor role here. After 20 minutes of post irradiation time, which corresponds to the 
moment of removing the films from the water phantom, the dose equivalent rate is of the order of 
20-50 pSv/s on the beam central axis at the rear of the water phantom. Thus we can conclude that 
neutron and proton production due to irradiation of VHEEs does not significantly affect the 
equivalent doses. In summary, the induced radioactivity from neutron fluence is found to be small 
and therefore it has negligible effect on total dose deposition.  
 
The investigated LWFA VHEE beams have characteristics unlike conventional radiotherapy 
beams. Relativistic effects of these beams resulting of their high energies and ultra-short duration 
(few fs) in the dose delivery could cause the different response to irradiation in tissue (Malka et al., 
2010) compared with conventional LINAC produced electrons and photons. These features could 
make a VHEE beam an interesting candidate as a new modality in radiotherapy, with advantages 
over existing methods. It is therefore important to compare VHEEs with other radiotherapy sources, 
including ions.  
There have been several investigations considering radiochromic films as a dosimetric tool in 
proton therapy (Zhao & Das, 2010, Kirby et al., 2010, Angellier et al., 2011). These studies show 
an under-response of EBT film at the Bragg peak, which suggest a film response dependence on 
LET. However, in our work we have not observed any difference in film response for low and very 
high energy electron beams. The LET spectra shown in Figure 8, has been calculated using a MC 
method. When comparing the calculated LET spectra for 20 MeV and VHEE beams one notices an 
upshift of the LET peak for LWFA VHEEs, however this difference is small. Because the LET 
spectra for both beams, low energy electrons and VHEEs, are very similar one could expect the 




The results of this study demonstrate that the EBT2 Gafchromic film is a reliable dosimeter for 
ultra-short pulses of very high energy electron beams generated by laser-plasma accelerators. Our 
study indicates energy-independence of EBT2 Gafchromic film over the investigated electron 
energies. The dosimetry with EBT2 Gafchromic film assures measurement of the dose for the non-
equilibrium, small field of very high energy electrons within 3.5 -5.4% of experimental uncertainty. 
Monte Carlo simulations with the FLUKA general-purpose code confirm the EBT2 Gafchromic 
film method of dosimetry and demonstrate the usefulness of the code for interpreting experimental 
studies using very high energy electron beams in the range of 130-170 MeV. It has also been 
calculated that the neutron yield is lower than predicted in early studies of VHEE (DesRosiers et al., 
2000). EBT2 dosimetry will underpin any further work aiming to demonstrate versatility of 
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